The Importance of Serum Fibroblast Growth Factor-23 in Obesity and Metabolic Syndrome, Potential Effect of Nutritional Therapy Intervention

Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients

Fibroblast growth factor-21 is a novel linkage between metabolic parameters, cardiovascular risk, and nephropathy in prediabetes

Serum levels of fibroblast growth factor-21 (FGF 21) in coronary heart disease

Biochemical studies on the interelationship between insulin, leptin and thyroid function in diabetic patients

Circulating Irisin In Relation To Obesity and Anorexia Nervosa in Patients with Type 2 Diabetes

Serum Fibroblast Growth Factor 21 and Its Relation to Diabetic Kidney (DKD) Disease and Cardiovascular Risk (ASCVD) in Type 2 Diabetic Patients

Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients

Correlation of Fibroblast Growth Factor 21 (FGF-21) with Fetal and Maternal Complications in Patients with Gestational Diabetes Mellitus

Studying the Role of Irisin, Chemerin and Some Other Hormonal Levels in Obese, Diabetic (type II) and Sub-Fertile Men